Instem says softening demand to affect second half
Instem PLC (AIM:INS) posted a loss in its latest half-year and cautioned the trading outlook for the rest of the year had also softened. The biotech...
Source: proactiveinvestors.co.uk
Phil Reason News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Phil Reason. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Phil Reason Today - Breaking & Trending Today
UK software firm Instem snapped up by French private equity group Archimed SAS in £200m deal
Staffordshire-based Instem provides IT services used in drug development for the global life sciences market, employing around 500 staff worldwide,
Source: thisismoney.co.uk
UK software firm Instem snapped up by French private equity group Archimed SAS in £200m deal
Staffordshire-based Instem provides IT services used in drug development for the global life sciences market, employing around 500 staff worldwide,
Source: dailymail.co.uk
Instem strong order book will help it build on a strong 2022 performance
Instem PLC (AIM:INS), which supplies software used by some of the world’s biggest life sciences companies, said it had a strong order book that will help it...
Source: proactiveinvestors.co.uk
Instem PLC proves in step with groundbreaking market needs as it posts strong 2022 performance
Phil Reason, CEO of Instem PLC (AIM:INS), joined Proactive with details of the company's 2022 financial performance. The company grew revenues by 28% and...
Source: proactiveinvestors.co.uk